Opendoor Gets Russell Push, Key Test Nears
Opendoor Technologies shares traded near $5.37 in premarket Wednesday, down from Tuesday’s $5.41 close, after heavy
J-Star Moves Up in Premarket on $122.5 Million Texas Battery Deal Behind YMAT
J-Star Holding shares jumped 47% to $1.34 in U.S. premarket trading after the Taiwan firm detailed plans for a $122.5 million solid-state battery plant in Baytown, Texas. The company secured a $60
Sify Shares Stuck, India AI Data-Center Bet Draws Traders
Sify Technologies’ ADRs closed at $17.24 on Nasdaq, up 2 cents after volatile trading. Annual revenue rose 13% to 44.88 billion rupees, EBITDA increased 31%, but net loss widened to 1.37 billion rupees. Data-center services accounted for 39% of revenue, up 23% year-over-year. The Nasdaq Composite finished up 0.03% at 27,093.90.
Ondas Stock Climbs After Navy Balloon Deal — Why ONDS Is Back in Focus
Ondas Inc. shares rose about 2% to $13.76 after its World View unit won a $4.8 million U.S. Navy-linked contract for stratospheric balloon maritime surveillance. Trading volume topped 80 million shares. The company reported over $110 million in new orders for the quarter to date and raised its 2026 revenue target to at least $390 million. Ondas held $1.48 billion in cash and equivalents as of March 31.
Sabre Drops as AI Plays Drive Wall Street; Investors Look to What’s Next
Sabre Corporation shares fell 0.5% to $1.88 Tuesday afternoon, lagging a Wall Street rally led by AI stocks. Trading volume was light, with 1.66 million shares exchanged and market value near $747 million. Sabre’s Q1 revenue rose 8% to $760 million, but investors remain focused on debt and upcoming management comments at a June 10 conference. Travel stocks, including Expedia and Booking, also declined.
Liberty Broadband Slides; Market Focuses on Charter Deal Figure
Liberty Broadband Class C shares fell 0.9% to $33.13 at midday, closely tracking Charter Communications’ stock. The price is just below Charter’s all-stock offer, now valuing Liberty at $33.38 per share. No new updates have been posted by Liberty since a May 15 preferred dividend notice. Charter’s planned acquisition of Liberty remains on the original terms.
T. Rowe Price Gains as Retirement-Income Effort Gets First Major Test
T. Rowe Price shares rose 0.7% to $104.60 midday Tuesday after announcing a retirement-income partnership with Transamerica and TIAA. Assets under management climbed to $1.83 trillion in April, but net outflows reached $10.6 billion for the month. The firm set a $1.30 quarterly dividend, payable June 29. Veiel took over as president, keeping his CIO and co-head roles.
Quantum-Si Stock Jumps as Traders Bet on Proteus Launch — Here’s What Could Move QSI Next
Quantum-Si shares jumped 5.5% to $1.245 Tuesday, with no new company news, as traders focused on the Proteus platform launch expected later this year. Volume reached 3.1 million shares, market value near $270 million. First-quarter revenue fell 69% to $258,000, net loss widened to $21.7 million. The company reported $190.4 million in cash at March 31, enough to fund operations into Q2 2028.
AGNC Stock Flat at $10.23 as Investors Watch $2 Billion Dilution Risk
AGNC Investment Corp. traded flat at $10.23 early Tuesday after announcing a $2 billion at-the-market stock offering last week. The company reported a Q1 comprehensive loss of 18 cents per share and a 5.6% drop in tangible net book value to $8.38. AGNC’s 12-cent monthly dividend remains unchanged, with the latest payout set for June 9. Peers showed mixed moves as broader indexes hit record highs Monday.
Viasat stock falls after earnings but Wall Street stays put
Viasat shares fell 9.63% to $72.86 Monday, deepening a two-day slide to nearly 16% despite a new Lockheed Martin contract for NOAA’s C-130J “Hurricane Hunter” planes. Needham maintained its Buy rating and $90 target. Investors questioned if recent gains matched near-term earnings. The S&P 500 ETF rose 0.2% in early trading.
Quantum-Si Stock Jumps as Traders Bet on Proteus Launch — Here’s What Could Move QSI Next
Quantum-Si shares jumped 5.5% to $1.245 Tuesday, with no new company news, as traders focused on the Proteus platform launch expected later this year. Volume reached 3.1 million shares, market value near $270 million. First-quarter revenue fell 69% to $258,000, net loss widened to $21.7 million. The company reported $190.4 million in cash at March 31, enough to fund operations into Q2 2028.
AGNC Stock Flat at $10.23 as Investors Watch $2 Billion Dilution Risk
AGNC Investment Corp. traded flat at $10.23 early Tuesday after announcing a $2 billion at-the-market stock offering last week. The company reported a Q1 comprehensive loss of 18 cents per share and a 5.6% drop in tangible net book value to $8.38. AGNC’s 12-cent monthly dividend remains unchanged, with the latest payout set for June 9. Peers showed mixed moves as broader indexes hit record highs Monday.
Viasat stock falls after earnings but Wall Street stays put
Viasat shares fell 9.63% to $72.86 Monday, deepening a two-day slide to nearly 16% despite a new Lockheed Martin contract for NOAA’s C-130J “Hurricane Hunter” planes. Needham maintained its Buy rating and $90 target. Investors questioned if recent gains matched near-term earnings. The S&P 500 ETF rose 0.2% in early trading.
Ericsson stock rises following new buyback, Moody’s rating move
Ericsson’s B shares rose 2.04% to SEK 125.20 in Stockholm Tuesday after Moody’s raised its credit rating to Baa3 and the company disclosed new share buybacks. Volume reached 1.56 million shares, below the daily average. Ericsson repurchased 585,379 shares in late May under its SEK 15 billion buyback plan. The OMXS30 index also gained, up 1.38% to 3,137.23.
Nasdaq Filing Deadline Bears Down on Richtech Robotics Stock
Richtech Robotics shares rose 2.5% to $3.10 early Tuesday as investors awaited a delayed March-quarter report and watched for Nasdaq compliance updates. Nasdaq has given Richtech until July 21 to submit a plan after missing its 10-Q filing, risking delisting if not resolved. The company expects March-quarter revenue of about $1.4 million, up from $1.2 million a year ago, but those figures are still under review.
Merlin shares drop 11% ahead of June AI flight test
Merlin Inc shares fell 10.81% to $7.18 on Monday, underperforming the broader market, after the company announced management will attend three industry conferences in June. Merlin, which began trading as MRLN on Nasdaq in March, is seeking civil certification for its autonomous flight technology and is developing a C-130J program under a U.S. military contract. Roth Capital cut its price target to $15 from $25.
Booking Holdings Stock Drops as Middle East Risk Weighs on Travel Sector
Booking Holdings shares fell 0.4% to $166.54 in late-morning trading Wednesday, extending Tuesday’s 1.2% drop as U.S. stocks retreated from record highs and oil prices rose on Middle East tensions. Volume reached about 1.75 million shares. Expedia and Airbnb also slipped. Booking remains nearly 28% below its 52-week high after warning in April that conflict was hurting room-night growth.
SpaceX sets $75 billion price for Nasdaq IPO, Musk moves forward with rare listing
SpaceX will price its IPO at $135 per share, aiming to raise $75 billion and value the company near $1.75 trillion, sources told Reuters. The company plans to list on Nasdaq as soon as June 12 under the ticker SPCX, selling 555.6 million new shares. Starlink generated over two-thirds of revenue and $1.2 billion in profit last quarter, while other units posted losses. Elon Musk holds 85% of voting power.
FMAO Stock Drops 2.5% as Insider-Sale Filing Puts Quiet Ohio Bank on Watch
Farmers & Merchants Bancorp shares fell 2.5% to $27.35 in late-morning trading Wednesday, tracking declines across regional banks. The drop put the stock near its March 31 book value of $27.30 per share. The latest company news was a June 1 Form 144 notice for a proposed insider sale of 15,000 shares by director Andrew J. Briggs. No new operating results have been released since April.
MacroGenics Shares Pop on 2028 Cash Runway Focus
MacroGenics shares rose 4.1% to $4.22 Wednesday, outperforming biotech peers as investors revisited its cash position and clinical timeline. The company reported a Q1 net loss of $36.8 million on $20.8 million revenue, with $154.2 million in cash and marketable securities as of March 31, not including a recent $60 million payment. MacroGenics expects its funding to last into 2028. Broader U.S. markets traded lower.
TaskUs Stock Drops Sharply as AI Outsourcing Play Gets Tested Again
TaskUs shares fell 6.3% to $6.06 on the Nasdaq Wednesday, near session lows, as investors reacted to slowing growth and margin pressure despite rising AI services revenue. First-quarter service revenue rose 10.3% to $306.3 million, while adjusted EBITDA margin narrowed to 19.1%. The company reaffirmed its 2026 outlook but guided for slower Q2 growth. Broader tech and outsourcing stocks also declined.
Telesat Shares Drop Ahead of AGM With Lightspeed Concerns Returning
Telesat shares fell 5.1% to $47.57 early Wednesday on Nasdaq ahead of the company’s annual shareholder meeting. First-quarter revenue dropped 25% to C$87 million, with a net loss widening to C$151 million. Telesat has invested about C$2.7 billion in its Lightspeed LEO satellite project and aims for global service by early 2028. Competition from Starlink and Amazon remains a key concern for investors.
Kodiak AI Stock Barely Moves, But One $6.50 Number Is Still Steering the Trade
Kodiak AI shares slipped 2 cents to $6.96 Wednesday, trading near the $6.50 price from its recent $100 million private share sale. The company reported first-quarter revenue of $1.8 million and negative free cash flow of $35 million, ending March with $90.2 million in cash. Investors remain focused on Kodiak’s capital needs and scaling plans despite a new workplace award. Aurora Innovation shares also traded lower.
Willis Lease Drops as Activist Battle Pushes June Vote Toward Dilution Showdown
Willis Lease Finance shares fell 1.6% to $171.79 Wednesday after activist group Four Tree Island Advisory urged investors to reject a proposed share count increase. The group wants the company to cancel a 300,000-share option grant, sell a superyacht and a jet, and limit Willis-family equity awards. A virtual shareholder vote on the measure is set for June 23. Proposal 2 needs 80% approval to pass.
Frontdoor Shares Slip After Q1 Beat
Frontdoor Inc shares slipped nearly 1% to $61.31 early Wednesday on Nasdaq, trading without a fresh catalyst. The company last reported first-quarter revenue up 6% to $451 million and net income up 11% to $41 million. Market cap stood near $4.43 billion. Contract claims costs rose $6 million in Q1, partly due to inflation and bad weather.
Uni-Fuels Stock Drops Premarket as Shareholders Face a Big Vote Next Week
Uni-Fuels Holdings shares dropped 12% to $0.66 in U.S. premarket trading Wednesday ahead of a June 8 shareholder vote on major changes to its capital structure. The company posted a first-quarter net loss of $376,087 despite revenue rising 64% to $83.2 million. The stock has swung between $0.60 and $11.00 over the past year. Brent crude rose 2.1% to $98.02 a barrel amid renewed Middle East tensions.
FTAI Infrastructure Shares Edge Down as $1.52 Billion Debt Reset Looms
FTAI Infrastructure Inc. traded at $4.48 in premarket Wednesday, unchanged after a 1.97% drop Tuesday. The company expects to close its $1.52 billion Long Ridge sale in the third quarter, pending regulatory approval. FTAI swung to a $150.2 million net loss in Q1 but reported higher adjusted EBITDA. Investors are watching rail operations and the outcome of the Long Ridge deal amid debt concerns.
Mineralys Stock Drops Before Open After $150 Million Sale Tests Blood-Pressure Drug Bet
Mineralys Therapeutics shares dropped 8.7% premarket after the company priced a $150 million stock offering at $26.50 a share to fund a $200 million royalty buyout with Tanabe Pharma. The company also secured a five-year, $500 million term loan from Pharmakon Advisors. Lorundrostat, its lead hypertension drug, is under FDA review with a decision expected by December 2026. AstraZeneca’s rival drug Baxfendy was approved in May.
Sallie Mae Hovers Near $22 Ahead of Major Loan Test
SLM Corp. traded near $22.05 in premarket action Wednesday, steady ahead of a June 4 dividend record date. Sallie Mae Fund expanded its graduate scholarships to 20 awards of $10,000 and 50 new awards up to $2,500, with applications open until July 17. Private Education Loan originations rose to $2.91 billion in Q1, with graduate loans at $217.7 million.
AN2 Therapeutics Shares Slip; Pipeline Update Due This Week May Be Next Driver
AN2 Therapeutics shares closed at $4.07, down 3% ahead of CEO Eric Easom’s June 4 presentation at the Jefferies Global Healthcare Conference. Principal Accounting Officer Sarah Joanne Williams sold 265 shares on May 29 for tax withholding. AN2 holds $85.3 million in cash after a recent private placement and expects multiple Phase 2 trial readouts this year. No major press releases have been issued in the past 48 hours.
Opendoor Gets Russell Push, Key Test Nears
Opendoor Technologies shares traded near $5.37 in premarket Wednesday, down from Tuesday’s $5.41 close, after heavy volume driven by its upcoming Russell 3000 inclusion set for June 26. CEO Kaz Nejatian is urging shareholders to vote before the June 11 annual meeting, as proxy advisors recommended voting against his board seat. First-quarter revenue fell to $720 million, with a net loss of $173 million.
Verrica Shares Drop With Jefferies Conference Ahead, Cash Warning Still in Focus
Verrica Pharmaceuticals closed Tuesday at $5.80, down 2.2%, and last traded at $5.79 ahead of a June 4 investor presentation. The company reported $5 million in first-quarter revenue and a $9.7 million net loss, with $20.6 million in cash as of March 31. Analyst Raghuram Selvaraju rated the stock Buy with a $12 target. No new filings or product updates have been released in the past 48 hours.
Baiya’s 90-cent Nasdaq shares watch CEO handover as board shifts
Baiya International shares fell 2.2% to $0.9009 in U.S. pre-market trading after CEO and chair Siyu Yang resigned effective June 1, with Linxi Xie named as successor. The company recently reported $35,216.58 in realized revenue from its digital asset trading plan. Fiscal 2025 revenue rose 28.6% to $16.5 million, but net loss widened to $9.5 million.
Advanced Biomed Stock Inches Up Before Nasdaq Opens As AI Pivot Faces Its First Real Tests
Advanced Biomed Inc. shares rose to $4.4135 premarket Wednesday, up 8.5 cents. The company recently acquired Acellent Technologies for $1.08 million and shifted focus from life sciences to artificial intelligence. Xiaomin Chen replaced Yi Lu as CEO and chairman in April. The firm reported a $488,942 net loss last quarter.
J-Star Moves Up in Premarket on $122.5 Million Texas Battery Deal Behind YMAT
J-Star Holding shares jumped 47% to $1.34 in U.S. premarket trading after the Taiwan firm detailed plans for a $122.5 million solid-state battery plant in Baytown, Texas. The company secured a $60 million outbound investment authorization from Taiwan’s central bank and a site commitment from Baytown’s economic development group. J-Star still awaits a U.S. Department of Energy grant decision. A reverse split vote is set for June 8.
PDS Biotechnology Stock Gets Nasdaq Extension as Traders Eye PDSB
PDS Biotechnology shares closed at $1.16 Tuesday after Nasdaq confirmed the company regained compliance with its $1 minimum bid rule, ending a delisting threat. The stock had traded under $1 for 30 days earlier this year. PDSB’s market value stands at about $64 million. The company continues to face clinical trial and financing risks.